ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,966Medicare Part D Prescriptions Filled, Including Refills

Rank: 201 out of 1121

$714K Total Retail Price of All Prescriptions

Rank: 202 out of 1121

598 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
13% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 598 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

14% of this provider’s 598 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 11,826 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
AMLODIPINE BESYLATE 787 753 1 5
SIMVASTATIN 743 695 2 1
OMEPRAZOLE 472 425 3 6
LEVOTHYROXINE SODIUM 452 439 4 2
LISINOPRIL 378 349 5 4
LOSARTAN POTASSIUM 377 345 6 17
ZOLPIDEM TARTRATE 338 302 7 19
FUROSEMIDE 259 239 8 7
HYDROCODONE-ACETAMINOPHEN 258 217 S3 9 3
HYDROCHLOROTHIAZIDE 257 246 10 10
ATORVASTATIN CALCIUM 225 215 11 15
ALLOPURINOL 223 201 12 30
CITALOPRAM HBR 206 197 13 18
ATENOLOL 205 193 14 16
METOPROLOL TARTRATE 193 190 15 9
WARFARIN SODIUM 188 177 16 11
GABAPENTIN 176 152 17 13
FLUTICASONE PROPIONATE 165 152 18 36
TAMSULOSIN HCL 159 135 19 32
ZETIA 151 149 20 80
DIOVAN 150 147 21 45
METOPROLOL SUCCINATE 145 131 22 23
METFORMIN HCL 142 136 23 8
GLIMEPIRIDE 127 119 24 34
SPIRONOLACTONE 124 118 25 54
CYMBALTA 121 102 26 50
ENALAPRIL MALEATE 117 115 27 73
DONEPEZIL HCL 116 116 28 35
NEXIUM 113 95 29 24
LOVASTATIN 113 98 29 26
PANTOPRAZOLE SODIUM 103 91 31 29
LOSARTAN-HYDROCHLOROTHIAZIDE 99 99 32 46
ESCITALOPRAM OXALATE 97 79 33 94
MELOXICAM 96 94 34 22
ALENDRONATE SODIUM 95 83 35 37
TRAZODONE HCL 88 79 36 40
AMITRIPTYLINE HCL 88 79 R 36 61
PREDNISONE 84 78 38 43
POTASSIUM CHLORIDE 81 74 39 12
SERTRALINE HCL 76 76 40 21
NAMENDA 75 75 41 53
CRESTOR 73 67 42 28
PRAVASTATIN SODIUM 69 56 43 14
PREMARIN 69 48 R 43 96
TRIAMTERENE-HCTZ 65 57 45 38
FINASTERIDE 65 56 45 117
PEN NEEDLE 60 56 47 137
CARVEDILOL 60 43 47 20
CLOPIDOGREL 59 59 49 27
AZITHROMYCIN 56 49 50 44
LYRICA 56 46 50 76
PAROXETINE HCL 54 31 52 58
MIRTAZAPINE 54 51 52 56
SYNTHROID 53 38 54 55
LANTUS 50 44 55 52
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 12, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.